c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation

Immunity

Volumn 6, Issue 2, 1997, Pages 165-174

  Wang, Weihong ^a   Tam, Winnie F ^a   Hughes, Christopher C W ^b   Rath, Satyajit ^c   Sen, Ranjan ^a  

^a BRANDEIS UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MESSENGER RNA; PENTOXIFYLLINE; TACROLIMUS; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE;

EID: 0030907779     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80423-9     Document Type: Article

References (42)

1. Bellas, R.E., Lee, J.S., and Sonenshein, G.E. (1995). Expression of a constitutive NF-κB-like activity is essential for proliferation of culture bovine vascular smooth muscle cells. J. Clin. Invest. 96, 2521-2527.
2. Bemelmans, M.H., Abramowicz, D., Gouma, D.J., Goldman, M., and Buurman, W.A. (1994). In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice: effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-γ antibodies. J. Immunol. 153, 499-506.
3. Biswas, D.K., Dezube, B.J., Ahlers, C.M., and Pardee, A.B. (1993a). Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-κB action. J. Acquir. Immune Defic. Syndr. 6, 778-786.
4. Biswas, D.K., Ahlers, C.M., Dezube, B.J., and Pardee, A.B. (1993b). Cooperative inhibition of NF-κB and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat. Proc. Natl. Acad. Sci. USA 90, 11044-11048.
5. Chen, D., and Rothenberg, E.V. (1994). Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 179, 931-942.
6. Cross, S.L., Halden, N.F., Lenardo, M.J., and Leonard, W.J. (1989). Functionally distinct NF-κB binding sites in the immunoglobulin κ and IL-2 receptor α chain genes. Science 244, 466-469.
7. Emmel, E.A., Verweij, C.L., Durand, D.B., Higgins, K.M., Lacy, E., and Crabtree, G.R. (1989). Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation. Science 246, 1617-1620.
8. Flanagan, W.M., Corthesy, B., Bram, R.J., and Crabtree, G.R. (1991). Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352, 803-807.
9. Fraser, J.D., Irving, B.A., Crabtree, G.R., and Weiss, A. (1991). Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251, 313-316.
10. Hughes, C.C., and Pober, J.S. (1996). Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells: convergence of costimulatory signals and differences from transformed T cells. J. Biol. Chem. 271, 5369-5377.
11. Kiley, P.D., Gillespie, K.M., and Oliveira, D.B. (1995). Oxpentifylline inhibits tumor necrosis factor-α mRNA transcription and protects against arthritis in mercuric chloride-treated brown Norway rats. Eur. J. Immunol. 25, 2899-2906.
12. Köntgen, F., Grumont, R.J., Strasser, A., Metcalf, D., Li, R., Tarlintou, D., and Gerondakis, S. (1995). Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9, 1965-1977.
13. Kovach, N.L., Lindgren, C.G., Fefer, A., Thompson, J.A., Yednock, T., and Harlan, J.M. (1994). Pentoxifylline inhibits integrin-mediated adherence of interleukin-2-activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and culture tumor cells. Blood 84, 2234-2242.
14. Ledebur, H.C., and Parks, T.P. (1995). Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells: essential roles of a variant NF-κB site and p65 homodimers. J. Biol. Chem. 270, 933-943.
15. Leung, K., and Nabel, G.J. (1988). HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature 333, 776-778.
16. Lowenthal, J.W., Ballard, D.W., Bönhlein, E., and Greene, W.C. (1989). Tumor necrosis factor α induces proteins that bind specifically to κB-like enhancer elements and regulate interleukin-2 receptor α-chain gene expression in primary human T lymphocytes. Proc. Natl. Acad. Sci. USA 86, 2331-2335.
17. Mauxion, F., and Sen, R. (1989). Alteration of a single nucleotide allows efficient binding of H2TF1/κBF1 to immunoglobulin κ enhancer B motif. Mol. Cell. Biol. 9, 3548-3552.
18. Mauxion, F., Jamieson, C., Yoshida, M., Arai, K., and Sen, R. (1991). Comparison of constitutive and inducible transcriptional enhancement mediated by κB-related sequences: modulation of activity in B cells by human T-cell leukemia virus type I tax gene. Proc. Natl. Acad. Sci. USA 88, 2141-2145.
19. Miller, J., Malek, T.R., Leonard, W.J., Greene, W.C., Shevack, E.M., and Germain, R.N. (1985). Nucleotide sequence and expression of a mouse interleukin 2 receptor cDNA. J. Immunol. 134, 4212-4217.
20. Montgomery, K.F., Osborn, L., Hession, C., Tizard, R., Goff, D., Vassallo, C., Tarr, P.I., Bomsztyk, K., Lobb, R., and Harlan, J.M. (1991). Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc. Natl. Acad. Sci. USA 88, 6523-6527.
21. Neish, A.S., Williams, A.J., Palmer, H.J., Whiteley, M.Z., and Collins, T. (1992). Functional analysis of the human vascular cell adhesion molecule 1 promoter. J. Exp. Med. 176, 1583-1593.
22. Nelsen, B., Kadesch, T., and Sen, R. (1990). Complex regulation of the immunoglobulin μ heavy-chain gene enhancer: μB, a new determinant of enhancer function. Mol. Cell. Biol. 10, 3145-3154.
23. Neuman, M., Grieschammer, T., Chuvpilo, S., Kneitz, B., Lohoff, M., Schimpl, A., Franza, B.R., and Serfling, E. (1995). ReIA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14, 1991-2004.
24. Northrop, J.P., Ho, S.N., Chen, L., Thomas, D.J., Timerman, L.A., Nolan, G.P., Admon, A., and Crabtree, G.R. (1994). NF-AT components define afamily of transcription factors targeted in T-cell activation. Nature 369, 497-502.
25. Pierce, J.W., Jamieson, C.A., Ross, J.L., and Sen, R. (1995). Activation of IL-2 receptor α-chain gene by individual members of the rel oncogene family in association with serum response factor. J. Immunol. 155, 1972-1980.
26. Rao, K.M., Currie, M.S., McCachren, S.S., and Cohen, H.J. (1991). Pentoxifylline and other methylxanthines inhibit interleukin-2 receptor expression in human lymphocytes. Cell. Immunol. 135, 314-325.
27. Rott, O., Cash, E., and Fleischer, B. (1993). Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur. J. Immunol. 23, 1745-1751.
28. Ruben, S., Poteat, H., Tan, T.-H., Kawakami, K., Roeder, R., Haseltine, W., and Rosen, C. (1988). Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science 241, 89-92.
29. Schindler, U., and Baichwal, V.R. (1994). Three NF-κB binding sites in the human E-selectin gene required for maximal tumor necrosis factor α-induced expression. Mol. Cell. Biol. 14, 5820-5831.
30. Shirakawa, F., Chedid, M., Suttles, J., Pollok, B.A., and Mizel, S.B. (1989). Interleukin 1 and cyclic AMP induce κ immunoglobulin light-chain expression via activation of an NF-κB-like DNA-binding protein. Mol. Cell. Biol. 9, 959-964.
31. Sinha, B., Semmler, J., Eisenhut, T., Eigler, A., and Endres, S. (1995). Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids. Eur. J. Immunol. 25, 147-153.
32. Streiter, R.M., Remick, D.G., Ward, P.A., Spengler, R.N., Lynch, J.P., Larrick, J., and Kunkel, S.L. (1988). Cellular and molecular regulation of tumor necrosis factor-α production by pentoxifylline. Biochem. Biophys. Res. Commun. 155, 1230-1236.
33. Takahashi, G.W., Montgomery, R.B., Stahl, W.L., Crittenden, C.A., Valentine, M.A., Thorning, D.R., Andrews, D.V., and Lilly, M.B. (1994). Pentoxifylline inhibits tumor necrosis factor-α-mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells. Int. J. Immunopharmacol. 16, 723-736.
34. 2+ signals and immunosuppression. Nature 383, 837-840.
35. Tozawa, K., Sakurada, S., Kohri, K., and Okamoto, T. (1995). Effects of anti-nuclear factor KB reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res. 55, 4162-4267.
36. Ullman, K.S., Northrop, J.P., Verweij, C.L., and Crabtree, G.R. (1990). Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu. Rev. Immunol. 8, 421-452.
37. Utz, P.J., Durand, D.B., Toole, J.J., Emmel, E.A., and Crabtree, G.R. (1988). Identification of a putative regulator of early T cell activation genes. Science 241, 202-205.
38. Venkataraman, L., Francis, D., Liu, J., Rothstein, T.L., and Sen, R. (1994). Cyclosporin-A sensitive induction of NF-AT in murine B cells. Immunity 1, 189-196.
39. Venkataraman, L., Burakoff, S.J., and Sen, R. (1995). FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J. Exp. Med. 181, 1091-1099.
40. Venkataraman, L., Wang, W., and Sen, R. (1996). Differential regulation of c-Rel translocation in activated B and T cells. J. Immunol. 157, 1149-1155.
41. Verweij, C.L., Geerts, M., and Aarden, L.A. (1991). Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J. Biol. Chem. 266, 14179-14182.
42. Yang, K.D., Chuen, H.L., and Shaio, M.F. (1995). Pentoxifylline augments but does not antagonize TNFα-mediated neuroblastoma cell differentiation: modulation of calcium mobilization but not cAMP. Biochem. Biophys. Res. Commun. 211, 1006-1014.